Oakbrook Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$215K	–	359
2019 Q4	$215K	Sell	2,000 -600	-23%	-$64.5K	0.04%	553
2019 Q3	$234K	Sell	2,600 -2,300	-47%	-$207K	0.02%	545
2019 Q2	$414K	Buy	4,900 +2,400	+96%	+$203K	0.02%	430
2019 Q1	$220K	Buy	+2,500	New	+$220K	0.01%	568